BIOE•Bio Essence shareholders approved an amendment giving each preferred share 10,000 votes, compared with one vote per common share. No preferred shares are currently outstanding; holders of 34,396,000 common shares, or 63.93% of outstanding common stock as of October 19, 2026, supported the amendment.
Bio Essence shareholders authorized an amendment granting each preferred share 10,000 votes, compared with one vote per common share. Holders of 34,396,000 common shares, representing 63.93% of outstanding common stock on October 19, 2026, backed the amendment. No preferred shares are currently outstanding; the amendment would allow future preferred stock issuance to maintain or transfer control without diluting common stock holdings.
